Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients

ClinicalTrials.gov ID: NCT07051629

Public ClinicalTrials.gov record NCT07051629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 3:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Double-Blind, Placebo-Controlled, Randomized, Single and Multiple Ascending Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIF001 in Healthy Subjects and in a Patient Cohort With Epilepsy

Study identification

NCT ID: NCT07051629
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Suninflam Inc; Industry
Enrollment: 88 participants

Conditions and interventions

Conditions

Interventions

SIF001 Biological
Placebo Drug

Biological · Drug

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 15, 2025
Primary completion: Jan 14, 2027
Completion: Mar 14, 2027
Last update posted: Jun 14, 2026

2025 – 2027

United States locations

U.S. sites: 10
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
Center for Neurosciences	Tucson	Arizona	85718	Recruiting
Accel Research sites network	DeLand	Florida	32720	Recruiting
D&H Tamarac Research Center, LLC	Tamarac	Florida	33321	Recruiting
Encore Medical Research of Weston, LLC	Weston	Florida	33331	Recruiting
Hawaii Pacific Neuroscience, Comprehensive Epilepsy Center	Honolulu	Hawaii	96817	Recruiting
Mid-Atlantic Epilepsy and Sleep Center	Bathesda	Maryland	20817	Recruiting
Quest Research Institute	Farmington Hills	Michigan	48334	Recruiting
Dent Neurologic Institute	Amherst	New York	14226	Recruiting
OnSite Clinical Solutions, LLC	Charlotte	North Carolina	28277	Recruiting
Horizon Clinical Research Center	Cypress	Texas	77429	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07051629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 14, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07051629 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →